Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Wilhelmina G. M. Kroes"'
Autor:
Esther H.M. van Egmond, Xiaohang Qiao, Sabrina A.J. Veld, Inge Jedema, Wilhelmina G. M. Kroes, Jacques Neefjes, Marieke Griffioen, Kevin Rijs, Constantijn J.M. Halkes, Willem H. Zoutman, J.H. Frederik Falkenburg, Floris C. Loeff, Maarten H. Vermeer
Publikováno v:
American Journal of Hematology, 94(1), 93-102
American Journal of Hematology
American Journal of Hematology
Adult B‐lymphoblastic leukemia (B‐ALL) is a hematological malignancy characterized by genetic heterogeneity. Despite successful remission induction with classical chemotherapeutics and novel targeted agents, enduring remission is often hampered b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a815ef9a1d31ccfd96ff46120d1242ea
https://hdl.handle.net/1887/88087
https://hdl.handle.net/1887/88087
Autor:
Mehmet Dogrusöz, Pieter A. van der Velden, Martine J. Jager, Gregorius P M Luyten, Wilhelmina G. M. Kroes, Sjoerd H. van der Burg, T. Huibertus van Essen, Thorbald van Hall, Robert M. Verdijk, Gülçin Gezgin, Vonn Walter
Publikováno v:
Cancer Immunology, Immunotherapy, 66(7), 903-912
Cancer Immunology Immunotherapy, 66(7), 903-912. Springer Science+Business Media
Cancer Immunology, Immunotherapy
Cancer Immunology Immunotherapy, 66(7), 903-912. Springer Science+Business Media
Cancer Immunology, Immunotherapy
Uveal melanoma (UM) is characterized by a number of genetic aberrations that follow a certain chronology and are tightly linked to tumor recurrence and survival. Loss of chromosome 3, bi-allelic loss of BAP1 expression, and gain in chromosome 8q have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4b652ccf9c98e4163ae91f691e4b5e8
http://hdl.handle.net/1887/115729
http://hdl.handle.net/1887/115729
Autor:
Jhf Falkenburg, Wilhelmina G. M. Kroes, R. G. Vries, Maria W. Honders, C. Out, A. S. Al Hinai, Martine J. Jager, Pieter S. Hiemstra, Eva Schmelzer, Jelle J. Goeman, C. van Kooten, W.A.F. Marijt, Marieke Griffioen, Stefan Böhringer, Margot J. Pont, Ramin Monajemi, Anita N. Kremer, H.C. de Boer
Publikováno v:
PLoS Medicine, 11, 155
PLoS ONE [E], 11(5). Public Library of Science
PLoS ONE, Vol 11, Iss 5, p e0155165 (2016)
PLoS ONE, 11(5)
PLoS ONE
PLoS ONE [E], 11(5). Public Library of Science
PLoS ONE, Vol 11, Iss 5, p e0155165 (2016)
PLoS ONE, 11(5)
PLoS ONE
Cellular immunotherapy has proven to be effective in the treatment of hematological cancers by donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation and more recently by targeted therapy with chimeric antigen or T-cell re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44df62fb1a72e37097b212106d057c39
https://hdl.handle.net/1887/113973
https://hdl.handle.net/1887/113973